Literature DB >> 28766760

The methylation status and expression of human telomerase reverse transcriptase is significantly high in oral carcinogenesis.

Kazuya Haraguchi1, Naomi Yada2, Shinobu Sato3, Manabu Habu1, Mana Hayakawa1, Osamu Takahashi1, Masaaki Sasaguri1, Shigeori Takenaka3, Izumi Yoshioka4, Kou Matsuo2, Kazuhiro Tominaga1.   

Abstract

Telomerase activity is present in most cancers and is tightly regulated by the expression of human telomerase reverse transcriptase (hTERT). Hypermethylation in the promoter region of hTERT contributes to the regulation of hTERT expression. In this study, we investigated the methylation and expression of hTERT in oral squamous cell carcinoma (OSCC), oral leukoplakia, and normal oral mucosa. Furthermore, we investigated the significance of hTERT to the clinicopathological findings of OSCC. 35 OSCC, 50 oral leukoplakia (epithelial dysplasia n = 25, squamous cell hyperplasia n = 25), and 10 normal oral mucosa samples were investigated through methylation-specific PCR. Immunohistochemistry was analyzed in 35 OSCC, 50 oral leukoplakia, and 4 normal oral mucosa samples. The methylation and expression of hTERT increased from normal oral mucosa to oral leukoplakia to OSCC. In OSCC, all samples were methylated. However, partial methylation (20%) or unmethylation (80%), but never complete methylation, was observed in normal oral mucosa. Additionally, hTERT expression correlated with cervical lymph node metastasis. These results suggested that the methylation and expression of hTERT is high in oral carcinogenesis and may play an important role in oral cancer. hTERT expression may also be predictive of cervical lymph node metastasis.
© 2017 APMIS. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  DNA methylation; Human telomerase reverse transcriptase; oral leukoplakia; oral squamous cell carcinoma; telomerase

Mesh:

Substances:

Year:  2017        PMID: 28766760     DOI: 10.1111/apm.12723

Source DB:  PubMed          Journal:  APMIS        ISSN: 0903-4641            Impact factor:   3.205


  5 in total

1.  Human telomerase reverse transcriptase protein expression is associated with survival in patients with oral squamous cell carcinoma.

Authors:  Kazuya Haraguchi; Manabu Habu; Naomi Yada; Masaaki Sasaguri; Izumi Yoshioka; Kazuhiro Tominaga
Journal:  Int J Clin Exp Pathol       Date:  2022-01-15

Review 2.  Prognostic and Clinicopathological Significance of Telomerase Reverse Transcriptase Upregulation in Oral Cancer: A Systematic Review and Meta-Analysis.

Authors:  Miguel Ángel González-Moles; Eloísa Moya-González; Alberto García-Ferrera; Paola Nieto-Casado; Pablo Ramos-García
Journal:  Cancers (Basel)       Date:  2022-07-28       Impact factor: 6.575

3.  MiR-22-3p Regulates Cell Proliferation and Inhibits Cell Apoptosis through Targeting the eIF4EBP3 Gene in Human Cervical Squamous Carcinoma Cells.

Authors:  Kang-Tai Lv; Zhu Liu; Jie Feng; Wei Zhao; Tao Hao; Wen-Yan Ding; Jing-Ping Chu; Ling-Juan Gao
Journal:  Int J Med Sci       Date:  2018-01-01       Impact factor: 3.738

4.  Immunohistochemical expression of human telomerase reverse transcriptase in oral cancer and precancer: A case-control study.

Authors:  Namrata Mishra; Nishi Tandon; Naseem Fatima; Anand N Srivastava; Nirupma Lal; Vijay Kumar
Journal:  J Oral Maxillofac Pathol       Date:  2019 Sep-Dec

5.  Intron 4-5 hTERT DNA Hypermethylation in Merkel Cell Carcinoma: Frequency, Association with Other Clinico-pathological Features and Prognostic Relevance.

Authors:  Costantino Ricci; Luca Morandi; Francesca Ambrosi; Alberto Righi; Dino Gibertoni; Francesca Maletta; Claudio Agostinelli; Angelo Gianluca Corradini; Silvia Uccella; Silvia Asioli; Fausto Sessa; Stefano La Rosa; Mauro Giulio Papotti; Sofia Asioli
Journal:  Endocr Pathol       Date:  2021-04-28       Impact factor: 3.943

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.